Anales de la RANM

71 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 ETIOPATOGENIA Y TRATAMIENTO DE LOS ABSCESOS HEPÁTICOS PIÓGENOS Jiménez Romero C, et al. An RANM. 2025;142(01): 61 - 72 15. Lai KC, Cheng KS, Jeng LB, et al. Factors as- sociated with treatment failure of percuta- neous catheter drainage for pyogenic liver abscess in patients with hepatobiliar y-pan- creatic cancer. Am J Surg. 2013;205:52-57. 16. Rismiller K, Haaga J, Siegel C, Ammori JB. Pyogenic liver abscesses: a contemporar y analysis of management strategies at a ter- tiary institution. HPB. 2017;19:889-893. 17. Ng SSM, Lee JFY, Lai PBS. Role and outco- me of conventional surgery in the treatment of pyogenic liver abscess in the modern era of minimally invasive therapy. World J Gas- troenterol. 2008;14:747-751. 18. Mukthinuthalapati VVPK, Attar BM, Parra- Rodriguez L, Cabrera NL, Araujo T, Gandhi S. Risk factors, management, and outcomes of pyogenic liver abscess in a US safety net hospital. Dig Dis Sci. 2020;65:1529-1538. 19. Meddings L. Myers RP, Hubbard J, et al. A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gas- troenterol. 2010;105:117-124. 20. Chen YC, Lin CH, Chang SN, Shi ZY. Epi- demiology and clinical outcome of pyogenic liver abscess: an analysis from the Natio- nal Health Insurance Research Database of Taiwan, 2000-2011. J Microbiol Immunol In- fect. 2016;49:646-653. 21. Yin D, Ji C, Zhang S, et al. Clinical characte- ristics and management of 1572 patients with pyogenic liver abscess: a 12-year retrospecti- ve study. Liver Int. 2021;41:810-818. 22. Shi S, Xia W, Guo H, Kong H, Zheng S. Unique characteristics of pyogenic liver abscesses of biliary origin. Surgery. 2016;159:1316-1324. 23. Poovorawan K, Pan-ngum W, Soonthorn- worasiri N, et al. Burden of liver abscess and survival risk score in Thailand: a po- pulation-based score. Am J Trop Med Hyg. 2016;95:683-688. 24. Justo I, Vega V, Marcacuzco A, et al. Risk fac- tors indicating the need for surgical thera- py in patients with pyogenic liver abscesses. Langenbeck´s Arch Surg. 2023;408:97. 25. Kaplan GG, Gregson DB, Laupland KB. Popu- lation-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2:1032–1038. 26. Tan YM, Chung AYF, Chow PKH, et al. An ap- praisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm. Ann Surg. 2005;241:485-490. 27. Jepsen P, Vilstrup H, Schonheyder HC, So- rensen HT. A nationwide study of the inci- dence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977-2002. Aliment Pharmacol Ther. 2005;21:1185-1188. 28. Alkofer B, Dufay C, Parienti JJ, Lepennec V, Dargere S, Chiche L. Are pyogenic abscesses still a surgical concern? A Western experien- ce. HPB Surg. 2015;2012:316013. 29. Law ST, Li KK. Is hepatic neoplasm-related pyogenic liver abscess a distinct clinical en- tity? World J Gastroenterol. 2012;18:1110– 1116. 30. Tian LT, Yao K, Zhang XY, et al. Liver abs- cesses in adult patients with and without diabetes mellitus: An analysis of the clini- cal characteristics, features of the causative pathogens, outcomes and predictors of fata- lity : A report based on a large population, retrospective study in China. Clin Micro- biol Infect. 2012;18:E314–30. 31. Wang TY, Lai HC, Chen HH, et al (2021) Pyogenic liver abscess risk in patients with newly diagnosed type 2 diabetes mellitus: a nationwide, population-based cohort study. Front Med. 2021;8:675345. 32. Lin YT, Wang FD, Wu PF, Fung CP. Klebsie- lla pneumoniae liver abscess in diabetic pa- tients: association of glycemic control with the clinical characteristics. BMC Infect Dis. 2013;13:56. 33. Du Z, Zhou X, Zhao J, et al. Effect of diabetes mellitus on short-term prognosis of 227 pyo- genic liver abscess patients after hospitaliza- tion. BMC Infect Dis. 2020; 20:145. 34. Tachopoulou OA, Vogt DP, Henderson JM, Baker M, Keys TF. Hepatic abscess after li- ver transplantation: 1990-2000. Transplan- tation. 2003;75:79–83. 35. Nikeghbalian S, Salahi R, Salahi H, et al. He- patic abscesses after liver transplant: 1997- 2008. Exp Clin Transplant. 2009;7:256–260. 36. Jimenez-Romero C, Marcacuzco A, Caso O, et al. Pyogenic abscesses in liver trans- plantation recipients versus non-trans- plant population. Outcome and risk fac- tors of patient sur vival. Clin Transplant. 2023;e14966. 37. Kornasiewicz O, Hotowko W, Grat M, et al. Hepatic abscess: a rare complication af- ter liver transplantation. Clin Transplant. 2016;30:1230-1235. 38. Kornasiewicz O, Hotowko W, Grat M, et al. Hepatic abscess: a rare complication af- ter liver transplantation. Clin Transplant. 2016;30:1230-1235. 39. Cheng H-C, Chang W-L, Chen W-Y, Kao A-W, Chuang C-H, Sheu B-S. Long-term Outcome of Pyogenic Liver Abscess. J Clin Gastroenterol. 2008;42:1110–1115. 40. Kanellopoulou T, Alexopoulou A, Theodos- siades G, Koskinas J, Archimandritis AJ. Pyle- phlebitis: An overview of non-cirrhotic cases and factors related to outcome. Scand J Infect Dis. 2010;42(11–12):804–811. 41. Marcacuzco Quinto A, Nutu OA, San Ro- mán Manso R, et al. Complications of transarterial chemoembolization (TACE) in the treatment of liver tumors. Cir Esp. 2018;96(9):560–567. 42. Shin JU, Kim KM, Shin SW, et al. A predic- tion model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2014;46:813-817. 43. Jindal A, Pandey A, Sharma MK, et al. Mana- gement practices and predictors of outcome of liver abscess in adults: a series of 1630 pa- tients from a liver unit. J Clin Exp Hepatol. 2021;11:312-320.